Literature DB >> 27185751

Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice.

Chia-Hua Wu1, Shayan Mohammadmoradi1, Joel Thompson1, Wen Su1, Ming Gong1, Genevieve Nguyen1, Frédérique Yiannikouris2.   

Abstract

Adipose tissue dysfunction related to obesity is overwhelmingly associated with increased risk of developing cardiovascular diseases. In the setting of obesity, (pro)renin receptor (PRR) is increased in adipose tissue of mice. We sought to determine the physiological consequences of adipocyte-PRR deficiency using adiponectin-Cre mice. We report a unique model of adipocyte-PRR-deficient mice (PRR(Adi/Y)) with almost no detectable white adipose tissues. As a consequence, the livers of PRR(Adi/Y) mice were enlarged and demonstrated a marked accumulation of lipids. Adipocyte-specific deficiency of PRR increased systolic blood pressure and the concentration of soluble PRR in plasma. To determine whether adipocyte-PRR was involved in the development of obesity-induced hypertension, mice were fed a low-fat or a high-fat diet for 16 weeks. Adipocyte-PRR-deficient mice were resistant to diet-induced obesity. Both high-fat- and low-fat-fed PRR(Adi/Y) mice had elevated insulin levels. Interestingly, adipocyte-PRR deficiency improved glucose tolerance in high-fat-fed PRR(Adi/Y) mice. In response to feeding either low-fat or high-fat diets, systolic blood pressure was greater in PRR(Adi/Y) mice than in control mice. High-fat feeding elevated soluble PRR concentration in control and PRR(Adi/Y) mice. In vitro knockdown of PRR by siRNA significantly decreased mRNA abundance of PPARγ (peroxisome proliferator-activated receptor gamma), suggesting an important role for PRR in adipogenesis. Our data indicate that adipocyte-PRR is involved in lipid homeostasis and glucose and insulin homeostasis, and that soluble PRR may be a predictor of metabolic disturbances and play a role in systolic blood pressure regulation.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  adipocytes; blood pressure; glucose; insulin; lipids; prorenin receptor

Mesh:

Substances:

Year:  2016        PMID: 27185751      PMCID: PMC4900901          DOI: 10.1161/HYPERTENSIONAHA.115.06954

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  Qualitative and quantitative analyses of (pro)renin receptor in the medium of cultured human umbilical vein endothelial cells.

Authors:  Kazal Boron Biswas; Ahm Nurun Nabi; Yoshie Arai; Tsutomu Nakagawa; Akio Ebihara; Atsuhiro Ichihara; Tadashi Inagami; Fumiaki Suzuki
Journal:  Hypertens Res       Date:  2011-03-17       Impact factor: 3.872

2.  Soluble (pro)renin receptor and blood pressure during pregnancy: a prospective cohort study.

Authors:  Noriyoshi Watanabe; Kanako Bokuda; Takeo Fujiwara; Tomo Suzuki; Asako Mito; Satoshi Morimoto; Seung Chik Jwa; Makiko Egawa; Yoshie Arai; Fumiaki Suzuki; Haruhiko Sago; Atsuhiro Ichihara
Journal:  Hypertension       Date:  2012-10-08       Impact factor: 10.190

Review 3.  The interaction between prorenin, renin and the (pro)renin receptor: time to rethink the role in hypertension.

Authors:  Timothy L Reudelhuber
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

Review 4.  Prorenin receptor regulates more than the renin-angiotensin system.

Authors:  Dominik N Müller; Katrina J Binger; Fabian Riediger
Journal:  Ann Med       Date:  2012-06       Impact factor: 4.709

5.  Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension.

Authors:  Wencheng Li; Hua Peng; Theresa Cao; Ryosuke Sato; Sarah J McDaniels; Hiroyuki Kobori; L Gabriel Navar; Yumei Feng
Journal:  Hypertension       Date:  2012-04-23       Impact factor: 10.190

6.  Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive rats.

Authors:  Alexis A Gonzalez; Lucienne S Lara; Christina Luffman; Dale M Seth; Minolfa C Prieto
Journal:  Hypertension       Date:  2011-02-14       Impact factor: 10.190

7.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

Review 8.  New insights into the structure and function of fatty acid-binding proteins.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

9.  Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling.

Authors:  Cristina-Maria Cruciat; Bisei Ohkawara; Sergio P Acebron; Emil Karaulanov; Carmen Reinhard; Dierk Ingelfinger; Michael Boutros; Christof Niehrs
Journal:  Science       Date:  2010-01-22       Impact factor: 47.728

Review 10.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

View more
  24 in total

Review 1.  The (pro)renin receptor and its interaction partners.

Authors:  Jörg Peters
Journal:  Pflugers Arch       Date:  2017-06-15       Impact factor: 3.657

2.  (Pro)renin Receptor Is an Amplifier of Wnt/β-Catenin Signaling in Kidney Injury and Fibrosis.

Authors:  Zhen Li; Lili Zhou; Yongping Wang; Jinhua Miao; Xue Hong; Fan Fan Hou; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2017-03-07       Impact factor: 10.121

3.  Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ.

Authors:  Fei Wang; Renfei Luo; Chang-Jiang Zou; Shiying Xie; Kexin Peng; Long Zhao; Kevin T Yang; Chuanming Xu; Tianxin Yang
Journal:  JCI Insight       Date:  2020-04-09

4.  RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models.

Authors:  Nadine Haase; Donald J Foster; Mark W Cunningham; Julia Bercher; Tuyen Nguyen; Svetlana Shulga-Morskaya; Stuart Milstein; Sarfraz Shaikh; Jeff Rollins; Michaela Golic; Florian Herse; Kristin Kräker; Ivo Bendix; Meray Serdar; Hanna Napieczynska; Arnd Heuser; Alexandra Gellhaus; Kristin Thiele; Gerd Wallukat; Dominik N Müller; Babbette LaMarca; Ralf Dechend
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 5.  The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome.

Authors:  Nirupama Ramkumar; Donald E Kohan
Journal:  Kidney Int       Date:  2019-02-26       Impact factor: 10.612

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  Soluble Prorenin Receptor Increases Blood Pressure in High Fat-Fed Male Mice.

Authors:  Eva Gatineau; Ming C Gong; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

Review 8.  The prorenin receptor in the cardiovascular system and beyond.

Authors:  Matthew Hennrikus; Alexis A Gonzalez; Minolfa C Prieto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-03       Impact factor: 4.733

Review 9.  The (pro)renin receptor in health and disease.

Authors:  Atsuhiro Ichihara; Midori Sasaki Yatabe
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

10.  (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis.

Authors:  Liwei Ren; Yuan Sun; Hong Lu; Dien Ye; Lijuan Han; Na Wang; Alan Daugherty; Furong Li; Miaomiao Wang; Fengting Su; Wenjun Tao; Jie Sun; Noam Zelcer; Adam E Mullick; A H Jan Danser; Yizhou Jiang; Yongcheng He; Xiongzhong Ruan; Xifeng Lu
Journal:  Circ Res       Date:  2018-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.